Antoinette Price

发表

Disrupting LIN28 in atypical teratoid rhabdoid tumors reveals the importance of the mitogen activated protein kinase pathway as a therapeutic target

J. Biegel, B. Weissman, C. Eberhart, 2014, Oncotarget.

DiSCoVERing Innovative Therapies for Rare Tumors: Combining Genetically Accurate Disease Models with In Silico Analysis to Identify Novel Therapeutic Targets

J. Mesirov, P. Tamayo, P. Clemons, 2016, Clinical Cancer Research.

Altered gene expression in conjunctival squamous cell carcinoma

C. Eberhart, Wayne Yu, L. Asnaghi, 2016, Modern Pathology.

The TORC1/2 inhibitor TAK228 sensitizes atypical teratoid rhabdoid tumors to cisplatin-induced cytotoxicity

C. Eberhart, Sabrina Z. Wang, B. Orr, 2017, Neuro-oncology.

Inhibition of mTORC1 in pediatric low-grade glioma depletes glutathione and therapeutically synergizes with carboplatin

C. Eberhart, E. Raabe, M. Yuan, 2018, Neuro-oncology.

Unbiased Metabolic Profiling Predicts Sensitivity of High MYC-Expressing Atypical Teratoid/Rhabdoid Tumors to Glutamine Inhibition with 6-Diazo-5-Oxo-L-Norleucine

C. Eberhart, Sabrina Z. Wang, B. Orr, 2019, Clinical Cancer Research.

Inhibition of monocarboxylate transporter-4 depletes stem-like glioblastoma cells and inhibits HIF transcriptional response in a lactate-independent manner

C. Eberhart, B. Orr, E. Bar, 2014, Oncogene.

Cellular and Fibrillar Collagen Analyses in an Animal Model of Retinal Detachment-Related Proliferative Vitreoretinopathy Reveals a Defined Transition to Chronic Fibrosis

Yuchen Lu, S. Blackshaw, Mandeep Singh, 2022, bioRxiv.

Disrupting LIN28 in atypical teratoid rhabdoid tumors reveals the importance of the mitogen activated protein kinase pathway as a therapeutic target

J. Biegel, B. Weissman, C. Eberhart, 2014, Oncotarget.